Chemotherapy in advanced nasopharyngeal cancer

ONCOLOGY

Volumn 14, Issue 8, 2000, Pages 1223-1230

  Ali, Haythem ^a   Al Sarraf, Muhyi ^a,b,c  

^a Providence Cancer Institute   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; HUMAN; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; REVIEW; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034240907     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Fandi A, Altun M, Azli N, et al: Nasopharyngeal cancer, epidemiology, staging and treatment. Semin Oncol 21: 382-397, 1994.
2. Ho JHC: An epidemiological and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 4:183-197,1978.
3. Flores AD, Dickson RI, Riding K, et al: Cancer of the nasopharynx in British Columbia. Am J Clin Oncol 9:281-291, 1986.
4. Forastiere A, Goepfert H, Goffinet D, et al: NCCN practice guidelines for head and neck cancer. Oncology 12(7 A): 134-139, 1998.
5. Sham JST, Cheung YK, Choy D, et al: Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma. Int J Radial Oncol Biol Phys 26:787-792,1993.